{"entity":{"type":"insider","cik":"0001396782","url":"/insider/0001396782","json_url":"/insider/0001396782.json","name":"LANDBLOOM RONALD P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":4,"first":"2007-11-28","last":"2008-09-25","span_basis":"filed_date"},"name_variants":[{"name":"LANDBLOOM RONALD P","source":"filing","n_filings":4,"first_seen":"2007-11-28","last_seen":"2008-09-25"}],"transactions":[{"id":3526756,"accession":"0001181431-08-054476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-054476","line_url":"/filing/0001181431-08-054476#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001396782","owner_name":"LANDBLOOM RONALD P","owner_display_name":"LANDBLOOM RONALD P","owner_url":"/insider/0001396782","role":"Officer (VP, Medical and Regulatory)","role_mark":"O","role_mark_label":"Officer (VP, Medical and Regulatory)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Medical and Regulatory","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.01,"price_display":"11.01","price_state":"stated","total_value":55050.0,"total_display":"55,050.00","total_whole":"55,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-23","filed_date":"2008-09-25","scope":"insider"},{"id":2917419,"accession":"0001181431-08-050440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-050440","line_url":"/filing/0001181431-08-050440#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001396782","owner_name":"LANDBLOOM RONALD P","owner_display_name":"LANDBLOOM RONALD P","owner_url":"/insider/0001396782","role":"Officer (VP, Medical and Regulatory)","role_mark":"O","role_mark_label":"Officer (VP, Medical and Regulatory)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Medical and Regulatory","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":11.28,"price_display":"11.28","price_state":"stated","total_value":451200.0,"total_display":"451,200.00","total_whole":"451,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-25","filed_date":"2008-08-27","scope":"insider"},{"id":7706613,"accession":"0001209191-07-071998","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-071998","line_url":"/filing/0001209191-07-071998","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001396782","owner_name":"LANDBLOOM RONALD P","owner_display_name":"LANDBLOOM RONALD P","owner_url":"/insider/0001396782","role":"Officer (VP, Medical and Regulatory)","role_mark":"O","role_mark_label":"Officer (VP, Medical and Regulatory)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Medical and Regulatory","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.975288,"price_display":"14.98","price_state":"stated","total_value":74876.44,"total_display":"74,876.44","total_whole":"74,876","shares_owned_after":2528.0,"shares_owned_after_display":"2,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-26","filed_date":"2007-12-28","scope":"insider","n_lines":5},{"id":7214680,"accession":"0001209191-07-066590","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-07-066590","line_url":"/filing/0001209191-07-066590","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001396782","owner_name":"LANDBLOOM RONALD P","owner_display_name":"LANDBLOOM RONALD P","owner_url":"/insider/0001396782","role":"Officer (VP, Medical and Regulatory)","role_mark":"O","role_mark_label":"Officer (VP, Medical and Regulatory)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Medical and Regulatory","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.405532,"price_display":"14.41","price_state":"stated","total_value":72027.66,"total_display":"72,027.66","total_whole":"72,028","shares_owned_after":1701.0,"shares_owned_after_display":"1,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-26","filed_date":"2007-11-28","scope":"insider","n_lines":13}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Officer (VP, Medical and Regulatory)","n_filings":4,"first_seen":"2007-11-28","last_seen":"2008-09-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001396782","retrieved_at":"2026-08-23T09:25:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}